ID   SE1L1_HUMAN             Reviewed;         794 AA.
AC   Q9UBV2; Q6UWT6; Q9P1T9; Q9UHK7;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   12-APR-2005, sequence version 3.
DT   28-JUN-2023, entry version 188.
DE   RecName: Full=Protein sel-1 homolog 1;
DE   AltName: Full=Suppressor of lin-12-like protein 1;
DE            Short=Sel-1L;
DE   Flags: Precursor;
GN   Name=SEL1L; Synonyms=TSA305; ORFNames=UNQ128/PRO1063;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=10496078; DOI=10.1007/s100380050171;
RA   Harada Y., Ozaki K., Suzuki M., Fujiwara T., Takahashi E., Nakamura Y.,
RA   Tanigami A.;
RT   "Complete cDNA sequence and genomic organization of a human pancreas-
RT   specific gene homologous to Caenorhabditis elegans sel-1.";
RL   J. Hum. Genet. 44:330-336(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Pancreas;
RX   PubMed=10746565; DOI=10.1007/s004390051032;
RA   Biunno I., Bernard L., Dear P., Cattaneo M., Volorio S., Zannini L.,
RA   Bankier A., Zollo M.;
RT   "SEL1L, the human homolog of C. elegans sel-1: refined physical mapping,
RT   gene structure and identification of polymorphic markers.";
RL   Hum. Genet. 106:227-235(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   GLYCOSYLATION AT ASN-272.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [5]
RP   FUNCTION, INTERACTION WITH SYVN1, IDENTIFICATION IN A COMPLEX WITH SYVN1
RP   AND DERL2, AND SUBCELLULAR LOCATION.
RX   PubMed=16186509; DOI=10.1073/pnas.0505014102;
RA   Lilley B.N., Ploegh H.L.;
RT   "Multiprotein complexes that link dislocation, ubiquitination, and
RT   extraction of misfolded proteins from the endoplasmic reticulum membrane.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:14296-14301(2005).
RN   [6]
RP   GLYCOSYLATION, AND INTERACTION WITH ERLEC1; HSPA5; OS9 AND SYVN1.
RX   PubMed=18502753; DOI=10.1074/jbc.m709336200;
RA   Hosokawa N., Wada I., Nagasawa K., Moriyama T., Okawa K., Nagata K.;
RT   "Human XTP3-B forms an endoplasmic reticulum quality control scaffold with
RT   the HRD1-SEL1L ubiquitin ligase complex and BiP.";
RL   J. Biol. Chem. 283:20914-20924(2008).
RN   [7]
RP   INTERACTION WITH ERLEC1; OS9 AND SYVN1.
RX   PubMed=18264092; DOI=10.1038/ncb1689;
RA   Christianson J.C., Shaler T.A., Tyler R.E., Kopito R.R.;
RT   "OS-9 and GRP94 deliver mutant alpha1-antitrypsin to the Hrd1-SEL1L
RT   ubiquitin ligase complex for ERAD.";
RL   Nat. Cell Biol. 10:272-282(2008).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-431 AND ASN-608.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [9]
RP   INTERACTION WITH EDEM1.
RX   PubMed=19524542; DOI=10.1016/j.molcel.2009.05.018;
RA   Cormier J.H., Tamura T., Sunryd J.C., Hebert D.N.;
RT   "EDEM1 recognition and delivery of misfolded proteins to the SEL1L-
RT   containing ERAD complex.";
RL   Mol. Cell 34:627-633(2009).
RN   [10]
RP   INTERACTION WITH FOXRED2.
RX   PubMed=19706418; DOI=10.1073/pnas.0900742106;
RA   Riemer J., Appenzeller-Herzog C., Johansson L., Bodenmiller B.,
RA   Hartmann-Petersen R., Ellgaard L.;
RT   "A luminal flavoprotein in endoplasmic reticulum-associated degradation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:14831-14836(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   INTERACTION WITH LPL.
RX   PubMed=25066055; DOI=10.1016/j.cmet.2014.06.015;
RA   Sha H., Sun S., Francisco A.B., Ehrhardt N., Xue Z., Liu L., Lawrence P.,
RA   Mattijssen F., Guber R.D., Panhwar M.S., Brenna J.T., Shi H., Xue B.,
RA   Kersten S., Bensadoun A., Peterfy M., Long Q., Qi L.;
RT   "The ER-associated degradation adaptor protein Sel1L regulates LPL
RT   secretion and lipid metabolism.";
RL   Cell Metab. 20:458-470(2014).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH SYVN1.
RX   PubMed=26471130; DOI=10.1111/febs.13564;
RA   Hosokawa N., Wada I.;
RT   "Association of the SEL1L protein transmembrane domain with HRD1 ubiquitin
RT   ligase regulates ERAD-L.";
RL   FEBS J. 283:157-172(2016).
RN   [15]
RP   IDENTIFICATION IN THE HRD1 COMPLEX.
RX   PubMed=28827405; DOI=10.1242/jcs.206847;
RA   Schulz J., Avci D., Queisser M.A., Gutschmidt A., Dreher L.S., Fenech E.J.,
RA   Volkmar N., Hayashi Y., Hoppe T., Christianson J.C.;
RT   "Conserved cytoplasmic domains promote Hrd1 ubiquitin ligase complex
RT   formation for ER-associated degradation (ERAD).";
RL   J. Cell Sci. 130:3322-3335(2017).
RN   [16]
RP   INTERACTION WITH HUMAN CYTOMEGALOVIRUS PROTEIN UL148 (MICROBIAL INFECTION).
RX   PubMed=29997207; DOI=10.1128/jvi.00688-18;
RA   Nguyen C.C., Siddiquey M.N.A., Zhang H., Li G., Kamil J.P.;
RT   "Human Cytomegalovirus Tropism Modulator UL148 Interacts with SEL1L, a
RT   Cellular Factor That Governs Endoplasmic Reticulum-Associated Degradation
RT   of the Viral Envelope Glycoprotein gO.";
RL   J. Virol. 92:0-0(2018).
CC   -!- FUNCTION: Plays a role in the endoplasmic reticulum quality control
CC       (ERQC) system also called ER-associated degradation (ERAD) involved in
CC       ubiquitin-dependent degradation of misfolded endoplasmic reticulum
CC       proteins (PubMed:16186509, PubMed:29997207). Enhances SYVN1 stability.
CC       Plays a role in LPL maturation and secretion. Required for normal
CC       differentiation of the pancreas epithelium, and for normal exocrine
CC       function and survival of pancreatic cells. May play a role in Notch
CC       signaling. {ECO:0000250|UniProtKB:Q9Z2G6, ECO:0000269|PubMed:16186509,
CC       ECO:0000269|PubMed:29997207}.
CC   -!- SUBUNIT: Homodimer and homooligomer (By similarity). May form a complex
CC       with ERLEC1, HSPA5, OS9, and SYVN1 (PubMed:18502753, PubMed:18264092).
CC       Interacts with FOXRED2 and EDEM1 (PubMed:19524542, PubMed:19706418).
CC       Interacts with LPL (PubMed:25066055). Interacts with LMF1; may
CC       stabilize the complex formed by LPL and LMF1 and thereby promote the
CC       export of LPL dimers (By similarity). Component of the HRD1 complex,
CC       which comprises at least SYNV1/HRD1, DERL1/2, FAM8A1, HERPUD1/HERP,
CC       OS9, SEL1L and UBE2J1 (PubMed:16186509, PubMed:28827405). SYNV1
CC       assembles with SEL1L and FAM8A1 through its transmembrane domains, but
CC       interaction with its cytoplasmic domain is required to confer stability
CC       to FAM8A1 and enhance recruitment of HERPUD1 (PubMed:28827405). The
CC       interaction with SYNV1/HRD1 is direct (PubMed:26471130).
CC       {ECO:0000250|UniProtKB:Q9Z2G6, ECO:0000269|PubMed:16186509,
CC       ECO:0000269|PubMed:18264092, ECO:0000269|PubMed:18502753,
CC       ECO:0000269|PubMed:19524542, ECO:0000269|PubMed:19706418,
CC       ECO:0000269|PubMed:25066055, ECO:0000269|PubMed:26471130,
CC       ECO:0000269|PubMed:28827405}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with human cytomegalovirus
CC       protein UL148. {ECO:0000269|PubMed:29997207}.
CC   -!- INTERACTION:
CC       Q9UBV2; P00533: EGFR; NbExp=2; IntAct=EBI-358766, EBI-297353;
CC       Q9UBV2; O75460-1: ERN1; NbExp=2; IntAct=EBI-358766, EBI-15600828;
CC       Q9UBV2; Q8IWF2: FOXRED2; NbExp=6; IntAct=EBI-358766, EBI-10763361;
CC       Q9UBV2; Q16288: NTRK3; NbExp=2; IntAct=EBI-358766, EBI-3936704;
CC       Q9UBV2; Q13438: OS9; NbExp=11; IntAct=EBI-358766, EBI-725454;
CC       Q9UBV2; Q86TM6: SYVN1; NbExp=20; IntAct=EBI-358766, EBI-947849;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:16186509}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:16186509}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UBV2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UBV2-2; Sequence=VSP_013322, VSP_013323;
CC   -!- TISSUE SPECIFICITY: Highly expressed in pancreas.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:12754519,
CC       ECO:0000269|PubMed:18502753, ECO:0000269|PubMed:19159218}.
CC   -!- SIMILARITY: Belongs to the sel-1 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/42246/SEL1L";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB024763; BAA89204.1; -; Genomic_DNA.
DR   EMBL; AB020335; BAA87904.1; -; mRNA.
DR   EMBL; AF052059; AAF29413.1; -; mRNA.
DR   EMBL; AF157516; AAF24176.1; -; Genomic_DNA.
DR   EMBL; AF198647; AAL40905.1; -; Genomic_DNA.
DR   EMBL; AF198631; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198632; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198633; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198634; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198635; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198636; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198637; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198638; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198639; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198640; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198641; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198642; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198643; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198644; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198645; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198646; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AY358651; AAQ89014.1; -; mRNA.
DR   CCDS; CCDS58333.1; -. [Q9UBV2-2]
DR   CCDS; CCDS9876.1; -. [Q9UBV2-1]
DR   RefSeq; NP_001231913.1; NM_001244984.1. [Q9UBV2-2]
DR   RefSeq; NP_005056.3; NM_005065.5. [Q9UBV2-1]
DR   AlphaFoldDB; Q9UBV2; -.
DR   SMR; Q9UBV2; -.
DR   BioGRID; 112300; 251.
DR   CORUM; Q9UBV2; -.
DR   DIP; DIP-46259N; -.
DR   IntAct; Q9UBV2; 46.
DR   MINT; Q9UBV2; -.
DR   STRING; 9606.ENSP00000337053; -.
DR   TCDB; 3.A.16.1.4; the endoplasmic reticular retrotranslocon (er-rt) family.
DR   GlyConnect; 1669; 12 N-Linked glycans (5 sites).
DR   GlyCosmos; Q9UBV2; 6 sites, 11 glycans.
DR   GlyGen; Q9UBV2; 14 sites, 11 N-linked glycans (5 sites), 2 O-linked glycans (8 sites).
DR   iPTMnet; Q9UBV2; -.
DR   PhosphoSitePlus; Q9UBV2; -.
DR   SwissPalm; Q9UBV2; -.
DR   BioMuta; SEL1L; -.
DR   DMDM; 62512184; -.
DR   EPD; Q9UBV2; -.
DR   jPOST; Q9UBV2; -.
DR   MassIVE; Q9UBV2; -.
DR   MaxQB; Q9UBV2; -.
DR   PaxDb; Q9UBV2; -.
DR   PeptideAtlas; Q9UBV2; -.
DR   ProteomicsDB; 84077; -. [Q9UBV2-1]
DR   ProteomicsDB; 84078; -. [Q9UBV2-2]
DR   Antibodypedia; 13274; 287 antibodies from 30 providers.
DR   DNASU; 6400; -.
DR   Ensembl; ENST00000336735.9; ENSP00000337053.4; ENSG00000071537.14. [Q9UBV2-1]
DR   Ensembl; ENST00000555824.5; ENSP00000450709.1; ENSG00000071537.14. [Q9UBV2-2]
DR   GeneID; 6400; -.
DR   KEGG; hsa:6400; -.
DR   MANE-Select; ENST00000336735.9; ENSP00000337053.4; NM_005065.6; NP_005056.3.
DR   UCSC; uc001xvo.5; human. [Q9UBV2-1]
DR   AGR; HGNC:10717; -.
DR   CTD; 6400; -.
DR   DisGeNET; 6400; -.
DR   GeneCards; SEL1L; -.
DR   HGNC; HGNC:10717; SEL1L.
DR   HPA; ENSG00000071537; Tissue enriched (pancreas).
DR   MIM; 602329; gene.
DR   neXtProt; NX_Q9UBV2; -.
DR   OpenTargets; ENSG00000071537; -.
DR   PharmGKB; PA35639; -.
DR   VEuPathDB; HostDB:ENSG00000071537; -.
DR   eggNOG; KOG1550; Eukaryota.
DR   GeneTree; ENSGT00940000156671; -.
DR   HOGENOM; CLU_007931_2_1_1; -.
DR   InParanoid; Q9UBV2; -.
DR   OMA; DMLAKPR; -.
DR   OrthoDB; 1378605at2759; -.
DR   PhylomeDB; Q9UBV2; -.
DR   TreeFam; TF315257; -.
DR   PathwayCommons; Q9UBV2; -.
DR   Reactome; R-HSA-1912420; Pre-NOTCH Processing in Golgi.
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants are degraded by ERAD.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-901032; ER Quality Control Compartment (ERQC).
DR   SignaLink; Q9UBV2; -.
DR   BioGRID-ORCS; 6400; 90 hits in 1160 CRISPR screens.
DR   ChiTaRS; SEL1L; human.
DR   GeneWiki; SEL1L; -.
DR   GenomeRNAi; 6400; -.
DR   Pharos; Q9UBV2; Tbio.
DR   PRO; PR:Q9UBV2; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q9UBV2; protein.
DR   Bgee; ENSG00000071537; Expressed in body of pancreas and 211 other tissues.
DR   ExpressionAtlas; Q9UBV2; baseline and differential.
DR   Genevisible; Q9UBV2; HS.
DR   GO; GO:0036513; C:Derlin-1 retrotranslocation complex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0000836; C:Hrd1p ubiquitin ligase complex; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0000839; C:Hrd1p ubiquitin ligase ERAD-L complex; IMP:UniProtKB.
DR   GO; GO:0036503; P:ERAD pathway; IMP:UniProtKB.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0009306; P:protein secretion; ISS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0030970; P:retrograde protein transport, ER to cytosol; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0006641; P:triglyceride metabolic process; ISS:UniProtKB.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; TAS:ParkinsonsUK-UCL.
DR   CDD; cd00062; FN2; 1.
DR   Gene3D; 2.10.10.10; Fibronectin, type II, collagen-binding; 1.
DR   Gene3D; 1.25.40.10; Tetratricopeptide repeat domain; 3.
DR   InterPro; IPR000562; FN_type2_dom.
DR   InterPro; IPR036943; FN_type2_sf.
DR   InterPro; IPR013806; Kringle-like.
DR   InterPro; IPR006597; Sel1-like.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   PANTHER; PTHR11102:SF70; PROTEIN SEL-1 HOMOLOG 1; 1.
DR   PANTHER; PTHR11102; SEL-1-LIKE PROTEIN; 1.
DR   Pfam; PF00040; fn2; 1.
DR   Pfam; PF08238; Sel1; 12.
DR   PRINTS; PR00013; FNTYPEII.
DR   SMART; SM00059; FN2; 1.
DR   SMART; SM00671; SEL1; 11.
DR   SUPFAM; SSF81901; HCP-like; 3.
DR   SUPFAM; SSF57440; Kringle-like; 1.
DR   PROSITE; PS00023; FN2_1; 1.
DR   PROSITE; PS51092; FN2_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disulfide bond; Endoplasmic reticulum; Glycoprotein;
KW   Host-virus interaction; Membrane; Notch signaling pathway; Phosphoprotein;
KW   Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..794
FT                   /note="Protein sel-1 homolog 1"
FT                   /id="PRO_0000022294"
FT   TOPO_DOM        22..738
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        739..759
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        760..794
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          122..170
FT                   /note="Fibronectin type-II"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00479"
FT   REPEAT          183..218
FT                   /note="Sel1-like 1"
FT   REPEAT          219..254
FT                   /note="Sel1-like 2"
FT   REPEAT          255..290
FT                   /note="Sel1-like 3"
FT   REPEAT          291..326
FT                   /note="Sel1-like 4"
FT   REPEAT          373..409
FT                   /note="Sel1-like 5"
FT   REPEAT          410..446
FT                   /note="Sel1-like 6"
FT   REPEAT          447..482
FT                   /note="Sel1-like 7"
FT   REPEAT          483..518
FT                   /note="Sel1-like 8"
FT   REPEAT          519..554
FT                   /note="Sel1-like 9"
FT   REPEAT          627..662
FT                   /note="Sel1-like 10"
FT   REPEAT          664..699
FT                   /note="Sel1-like 11"
FT   REGION          21..50
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          22..737
FT                   /note="Interaction with ERLEC1, OS9 and SYVN1"
FT   REGION          64..109
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          352..537
FT                   /note="Important for homodimerization and oligomerization"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2G6"
FT   REGION          643..723
FT                   /note="Interaction with SYVN1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2G6"
FT   REGION          738..794
FT                   /note="Mediates retention in the endoplasmic reticulum"
FT   REGION          766..794
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        29..49
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        770..794
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         63
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   CARBOHYD        195
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        217
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        272
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12754519"
FT   CARBOHYD        431
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        608
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   DISULFID        127..153
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00479"
FT   DISULFID        141..168
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00479"
FT   VAR_SEQ         298..301
FT                   /note="GYRY -> VSRL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12975309"
FT                   /id="VSP_013322"
FT   VAR_SEQ         302..794
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12975309"
FT                   /id="VSP_013323"
FT   VARIANT         162
FT                   /note="D -> G (in dbSNP:rs11499034)"
FT                   /id="VAR_029303"
FT   VARIANT         714
FT                   /note="V -> I (in dbSNP:rs1051193)"
FT                   /id="VAR_053963"
FT   CONFLICT        186
FT                   /note="M -> V (in Ref. 2; AAF29413/AAL40905)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   794 AA;  88755 MW;  323EB03DC7485459 CRC64;
     MRVRIGLTLL LCAVLLSLAS ASSDEEGSQD ESLDSKTTLT SDESVKDHTT AGRVVAGQIF
     LDSEESELES SIQEEEDSLK SQEGESVTED ISFLESPNPE NKDYEEPKKV RKPALTAIEG
     TAHGEPCHFP FLFLDKEYDE CTSDGREDGR LWCATTYDYK ADEKWGFCET EEEAAKRRQM
     QEAEMMYQTG MKILNGSNKK SQKREAYRYL QKAASMNHTK ALERVSYALL FGDYLPQNIQ
     AAREMFEKLT EEGSPKGQTA LGFLYASGLG VNSSQAKALV YYTFGALGGN LIAHMVLGYR
     YWAGIGVLQS CESALTHYRL VANHVASDIS LTGGSVVQRI RLPDEVENPG MNSGMLEEDL
     IQYYQFLAEK GDVQAQVGLG QLHLHGGRGV EQNHQRAFDY FNLAANAGNS HAMAFLGKMY
     SEGSDIVPQS NETALHYFKK AADMGNPVGQ SGLGMAYLYG RGVQVNYDLA LKYFQKAAEQ
     GWVDGQLQLG SMYYNGIGVK RDYKQALKYF NLASQGGHIL AFYNLAQMHA SGTGVMRSCH
     TAVELFKNVC ERGRWSERLM TAYNSYKDGD YNAAVIQYLL LAEQGYEVAQ SNAAFILDQR
     EASIVGENET YPRALLHWNR AASQGYTVAR IKLGDYHFYG FGTDVDYETA FIHYRLASEQ
     QHSAQAMFNL GYMHEKGLGI KQDIHLAKRF YDMAAEASPD AQVPVFLALC KLGVVYFLQY
     IRETNIRDMF TQLDMDQLLG PEWDLYLMTI IALLLGTVIA YRQRQHQDMP APRPPGPRPA
     PPQQEGPPEQ QPPQ
//
